Historia de V. Michelle Bernard
El mes pasado, Fred Manchur, director financiero de Kettering Health, se retiró de su cargo.
“Ha sido la mayor bendición de mi vida trabajar junto a los increíbles profesionales médicos y el personal de Kettering Health durante más de 20 años”, dice Manchur.
Michael Mewhirter, actual director financiero, se desempeñará como director ejecutivo interino.
Story by Christina Keresoma
Hearing the word “cancer” brings anyone’s world to a stop. Life seems to freeze around as you try to comprehend everything that’s about to change.
The cancer journey affects the whole person—mind, body, and spirit. And it requires a community to navigate. That’s why at Kettering Health we stand behind our faith-based approach to bring to every cancer patient care that not only heals but also offers hope. Our dedicated cancer specialists treat patients with innovative treatments and a holistic approach, coming alongside patients and their families for every step of the journey. We’re no stranger to what it takes to help others fight cancer—and neither are our friends in the NFL.
Story by Kettering Health
Kettering Health announced it has named Michael Mewhirter, current chief financial officer (CFO), as interim chief executive officer (CEO). This appointment follows last week’s announcement that CEO Fred Manchur would be retiring after nearly 12 years in the role.
Statement by Kettering Health Staff
Kettering Health announced today that Chief Executive Officer Fred Manchur has decided to retire from his position effective December 31.
Story by Kettering Health Staff
Kettering Health has a new PET/CT digital extended-length scanner–the first of its kind in the Dayton region. The Siemens Vision 600 PET/ST camera provides more accurate images with shorter scan times and less radiation exposure for patients. Shorter scan times will allow for more appointment times.
This scanner is already being used to research Alzheimer’s disease and brain tumors. Kettering Health will soon begin using the scanner to research prostate and breast cancer.